Evidence map›Paper›PMID 29533006›Full record

ArticleCancer medicine2018

Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease.

John Michael Varlotto, Richard Voland, Kerrie McKie, John C Flickinger, Malcolm M DeCamp, Debra Maddox, Paul Rava, Thomas J Fitzgerald, Geoffrey Graeber, Negar Rassaei and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

John Michael VarlottoDepartment of Radiation Oncology, University of Massachusetts Medical Center, Worcester, Massachusetts.ORCID 0000-0002-7759-2951
Richard VolandSchool of Nursing, University of Wisconsin, Madison, Wisconsin.
Kerrie McKieUniversity of Massachusetts Medical School, Worcester, Massachusetts.
John C FlickingerDepartment of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Malcolm M DeCampDivision of Thoracic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Debra MaddoxDepartment of Medical Oncology, University of Massachusetts Medical Center, Worcester, Massachusetts.
Paul RavaDepartment of Radiation Oncology, University of Massachusetts Medical Center, Worcester, Massachusetts.
Thomas J FitzgeraldDepartment of Radiation Oncology, University of Massachusetts Medical Center, Worcester, Massachusetts.
Geoffrey GraeberUniversity of Massachusetts Medical School, Worcester, Massachusetts.
Negar RassaeiDepartment of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Paulo OliveiraUniversity of Massachusetts Medical School, Worcester, Massachusetts.
Suhail AliPenn State Hershey Cancer Institute, Hershey, Pennsylvania.
Chandra BelaniPenn State Hershey Cancer Institute, Hershey, Pennsylvania.
Jonathan GlanzmanDepartment of Radiation Oncology, University of Massachusetts Medical Center, Worcester, Massachusetts.
Heather A WakeleeDivision of Medical Oncology, Stanford University, Palo Alto, California.
Manali PatelDivision of Medical Oncology, Stanford University, Palo Alto, California.
Jennifer BaimaDepartment of Orthopedics and Rehabilitation, University of Massachusetts Medical Center, Worcester, Massachusetts.
Jianying ZhangDepartment of Quantitative Sciences, University of Massachusetts Medical School, Worcester, Massachusetts.
William WalshUniversity of Massachusetts Medical School, Worcester, Massachusetts.
University of Massachusetts Chan Medical School · USPenn State Milton S. Hershey Medical Center · USPalo Alto University · USNorthwestern University · USUniversity of Pittsburgh Medical Center · USUniversity of Wisconsin System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the interrelation between economic, marital, and known histopathologic/therapeutic prognostic factors in presentation and survival of patients with lung cancer in nine different ethnic groups. A retrospective review of the SEER database was conducted through the years 2007-2012. Population differences were assessed via chi-square testing. Multivariable analyses (MVA) were used to detect overall survival (OS) differences in the total population (TP, N = 153,027) and for those patients presenting with Stage IV (N = 70,968). Compared to Whites, Blacks were more likely to present with younger age, male sex, lower income, no insurance, single/widowed partnership, less squamous cell carcinomas, and advanced stage; and experience less definitive surgery, lower OS, and lung cancer-specific (LCSS) survival. White Hispanics presented with younger age, higher income, lower rates of insurance, single/widowed partnership status, advanced stage, more adenocarcinomas, and lower rates of definitive surgery, but no difference in OS and LCSS than Whites. In the TP and Stage IV populations, MVAs revealed that OS was better or equivalent to Whites for all other ethnic groups and was positively associated with insurance, marriage, and higher income. Blacks presented with more advanced disease and were more likely to succumb to lung cancer, but when adjusted for prognostic factors, they had a better OS in the TP compared to Whites. Disparities in income, marital status, and insurance rather than race affect OS of patients with lung cancer. Because of their presentation with advanced disease, Black and Hispanics are likely to have increased benefit from lung cancer screening.

Indexed as

EthnicityAgedAged, 80 and overFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedNeoplasm MetastasisNeoplasm StagingPatient Outcome AssessmentProportional Hazards ModelsSEER ProgramSocioeconomic FactorsSymptom AssessmentDisparitiesinsurancelung cancermarriagemetastatic lung canceroutcomesracesocio-economic factors

Identifiers

PMID29533006
PMCPMC5911616
OpenAlexW2791562720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.